Sales decline 1.54% to Rs 21.10 crore
Net Loss of Concord Drugs reported to Rs 1.33 crore in the quarter ended March 2018 as against net loss of Rs 1.78 crore during the previous quarter ended March 2017. Sales declined 1.54% to Rs 21.10 crore in the quarter ended March 2018 as against Rs 21.43 crore during the previous quarter ended March 2017.For the full year,net profit rose 100.00% to Rs 0.32 crore in the year ended March 2018 as against Rs 0.16 crore during the previous year ended March 2017. Sales declined 9.90% to Rs 51.80 crore in the year ended March 2018 as against Rs 57.49 crore during the previous year ended March 2017. ParticularsQuarter EndedYear EndedMar. 2018Mar. 2017% Var.Mar. 2018Mar. 2017% Var.Sales21.1021.43 -2 51.8057.49 -10 OPM %-1.18-3.50 -9.239.55 - PBDT-0.71-1.43 50 3.043.22 -6 PBT-1.39-2.15 35 0.640.64 0 NP-1.33-1.78 25 0.320.16 100
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)